GeneDx (WGS) PT Lowered to $100 at Canaccord
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Price: $59.92 -1.75%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Canaccord analyst Kyle Mikson lowered the price target on GeneDx (NASDAQ: WGS) to $100.00 (from $170.00) while maintaining a Buy rating.
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- The Lovesac Co. (LOVE) PT Raised to $20 at DA Davidson Following Q1 Results
- Glenmark Pharmaceuticals Ltd. (GNP:IN) PT Raised to INR2,750 at Investec
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
